Waldenström's macroglobulinemia epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 2: | Line 2: | ||
{{Waldenström's macroglobulinemia}} | {{Waldenström's macroglobulinemia}} | ||
{{CMG}}{{AE}}{{MGS}} | {{CMG}}{{AE}}{{MGS}} | ||
==Overview== | ==Overview== | ||
The prevalence of Waldenström's macroglobulinemia is estimated to be 1500 cases in United States annually. Waldenström's macroglobulinemia represents 1% of all hematological cancers.<ref name="wiki">Molecular pathogenesis of Waldenström’s macroglobulinemia NCBI (2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436227/ Accessed on November, 6 2015</ref> | The prevalence of Waldenström's macroglobulinemia is estimated to be 1500 cases in United States annually. Waldenström's macroglobulinemia represents 1% of all hematological cancers.<ref name="wiki">Molecular pathogenesis of Waldenström’s macroglobulinemia NCBI (2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436227/ Accessed on November, 6 2015</ref> | ||
| Line 12: | Line 13: | ||
==References== | |||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 19:00, 17 November 2015
|
Waldenström's macroglobulinemia Microchapters |
|
Differentiating Waldenström's macroglobulinemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Waldenström's macroglobulinemia epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Waldenström's macroglobulinemia epidemiology and demographics |
|
FDA on Waldenström's macroglobulinemia epidemiology and demographics |
|
CDC on Waldenström's macroglobulinemia epidemiology and demographics |
|
Waldenström's macroglobulinemia epidemiology and demographics in the news |
|
Blogs on Waldenström's macroglobulinemia epidemiology and demographics |
|
Directions to Hospitals Treating Waldenström's macroglobulinemia |
|
Risk calculators and risk factors for Waldenström's macroglobulinemia epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]
Overview
The prevalence of Waldenström's macroglobulinemia is estimated to be 1500 cases in United States annually. Waldenström's macroglobulinemia represents 1% of all hematological cancers.[1]
Epidemiology and Demographics
- Waldenström's macroglobulinemia represents 1% of all hematological cancers.[1]
- The prevalence of Waldenström's macroglobulinemia is estimated to be 1500 cases in United States annually.[2]
- World-wide, age-adjusted incidence of Waldenström's macroglobulinemia is 0.38 cases per 100,000 persons annually, increasing with age to 2.85 in patients above 80 years.[3]
References
- ↑ 1.0 1.1 Molecular pathogenesis of Waldenström’s macroglobulinemia NCBI (2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436227/ Accessed on November, 6 2015
- ↑ Waldenström’s macroglobulinemia Wikipedia (2015) https://en.wikipedia.org/wiki/Waldenström%27s_macroglobulinemia#cite_note-Cheson-1 Accessed on November, 6 2015
- ↑ Monge J, Braggio E, Ansell SM (2013). "Genetic factors and pathogenesis of Waldenström's macroglobulinemia". Curr Oncol Rep. 15 (5): 450–6. doi:10.1007/s11912-013-0331-7. PMC 3807757. PMID 23901022.